CFP announces new presidentPeter Marshall has been appointed president of the Canadian Foundation for Pharmacy for 2009. New indication for AclastaNovartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. Lax-A-Day: new PEG oral laxative PendoPharm/Pharmascience is introducing a new OTC osmotic laxative, Lax-A-Day (polyethylene glycol [PEG] 3350 powder for oral solution). Don't let terminal diagnosis end patient communicaiton PENSIONS: The European experience Faculties of medicine creating clearer rules for pharma funding Current mumps protection may not be enough Outbreaks prompt need to study cause of waning immunity, benefits of possible third dose of vaccine PENSIONS: Canadian pension rules outdated Clinical in Brief: Incidental findings common in cervical spine CTs PENSIONS: U.K. MDs special kind of self-employed First Previous 2209 2210 2211 2212 2213 Next Last
